CRYSTAL JONES: Open Payments
NPI 1356307003 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 58 payments from 25 companies in 2025. Trend: 2023 $1,103 · 2024 $1,035 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $200 |
| Kerecis Limited | 3 | $86 |
| Insmed, Inc. | 4 | $84 |
| GENZYME CORPORATION | 2 | $73 |
| Indivior Inc. | 3 | $65 |
| HARMONY BIOSCIENCES LLC | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| UCB, Inc. | 2 | $52 |
| ARGENX US, INC. | 3 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
Products named: Kerecis SurgiClose, Arikayce, KEVZARA, UBRELVY, SUBLOCADE, WAKIX, AUSTEDO XR, Briviact.
Industry payments across IN — which companies pay providers there.
